The electrophysiological and mechanical effects of HNS-32, a novel azulene-1-carboxamidine derivative with antiarrhythmic activity, were studied in isolated guinea-pig myocardial preparations. HNS-32 (10–6–10–4 mol/l) concentration-dependently decreased the maximum rate of rise (Vmax) of action potential in isolated papillary muscle; the potency was the same or slightly higher than that of disopyramide. At 10–4 mol/l, HNS-32 also shortened the action potential duration (APD) and depolarized the resting membrane potential; these effects were similar to those of 10–5 mol/l verapamil. HNS-32 (10–7–10–4 mol/l), as well as verapamil (10–8–10–5 mol/l) and disopyramide (10–6–10–3 mol/l), had concentration-dependent negative chronotropic and negative inotropic effects on isolated right atrial and right ventricular papillary muscle preparations, respectively. The concentration-response relationship for the positive chronotropic effect of isoproterenol was not affected by HNS-32 (10–5 mol/l). In isolated ventricular myocytes, HNS-32 (10–6–10–4 mol/l) concentration-dependently inhibited the peak amplitude of the L-type Ca2+ current. These results suggest that NHS-32 has Vmax reducing activity on myocardial tissue, which may be responsible for antiarrhythmic effect. The drug may also have additional effect on the Ca2+ channel at higher concentrations.